Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program

NCT01281657 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01281657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01281657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
Lead sponsor
Novartis
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
July 31, 2012
Enrollment
64 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis